IRIS
FALCONI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.171
EU - Europa 6.195
AS - Asia 2.506
SA - Sud America 633
AF - Africa 164
Continente sconosciuto - Info sul continente non disponibili 47
OC - Oceania 1
Totale 17.717
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.121
UA - Ucraina 1.630
RU - Federazione Russa 930
SG - Singapore 851
IE - Irlanda 811
DE - Germania 732
DK - Danimarca 625
BR - Brasile 583
HK - Hong Kong 566
SE - Svezia 516
TR - Turchia 423
IT - Italia 415
FI - Finlandia 347
KR - Corea 323
CN - Cina 212
MA - Marocco 113
GB - Regno Unito 94
EU - Europa 47
AT - Austria 36
CA - Canada 32
IN - India 27
CI - Costa d'Avorio 26
FR - Francia 21
IQ - Iraq 20
BD - Bangladesh 19
AR - Argentina 15
VN - Vietnam 14
BE - Belgio 12
ZA - Sudafrica 12
PK - Pakistan 10
MX - Messico 9
VE - Venezuela 8
NL - Olanda 7
PL - Polonia 7
JP - Giappone 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
JO - Giordania 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
DZ - Algeria 4
PE - Perù 4
PY - Paraguay 4
UZ - Uzbekistan 4
CL - Cile 3
JM - Giamaica 3
KE - Kenya 3
OM - Oman 3
SA - Arabia Saudita 3
TN - Tunisia 3
AM - Armenia 2
BO - Bolivia 2
GE - Georgia 2
HN - Honduras 2
KZ - Kazakistan 2
LB - Libano 2
TT - Trinidad e Tobago 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
GA - Gabon 1
IL - Israele 1
KG - Kirghizistan 1
LT - Lituania 1
MN - Mongolia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
Totale 17.717
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.628
Fairfield 1.006
Dublin 811
Boardman 661
Hong Kong 566
Wilmington 493
Ashburn 461
Singapore 455
Woodbridge 406
Houston 373
Seattle 350
San Mateo 330
Lawrence 328
Princeton 328
Chandler 305
Cambridge 288
Centro 276
Moscow 204
Ann Arbor 164
New York 140
San Diego 136
Des Moines 134
Beijing 49
Nuremberg 33
Saint Petersburg 33
São Paulo 33
Munich 29
Abidjan 26
London 23
Norwalk 21
Shanghai 21
Guangzhou 18
Turku 18
The Dalles 16
Vienna 15
Belo Horizonte 14
Rio de Janeiro 13
Brussels 12
Kilburn 12
Ottawa 11
Brasília 10
Curitiba 10
Ribeirão Preto 10
Wuhan 10
Dallas 9
Sorocaba 9
Campinas 8
Caxias do Sul 8
Helsinki 8
Hounslow 8
Izmir 8
Los Angeles 8
Rome 8
Salvador 8
Toronto 8
Istanbul 7
Porto Alegre 7
Atlanta 6
Chicago 6
Goiânia 6
Prescot 6
San Francisco 6
Verona 6
Amman 5
Baghdad 5
Dhaka 5
Duque de Caxias 5
Erbil 5
Milan 5
Olomouc 5
Piracicaba 5
Pune 5
Ribeirão das Neves 5
Rio Grande 5
Warsaw 5
Yiwu 5
Acton 4
Cape Town 4
Carapicuíba 4
Contagem 4
Fortaleza 4
Franca 4
Hanover 4
Ho Chi Minh City 4
Jinhua 4
João Pessoa 4
Juiz de Fora 4
Limeira 4
Natal 4
Pelotas 4
Shenzhen 4
Stockholm 4
Tashkent 4
Tokyo 4
Viamão 4
Basra 3
Belém 3
Blumenau 3
Boston 3
Bragança Paulista 3
Totale 10.576
Salva come PNG Salva come JPEG
Nome #
Poorly differentiated resectable pancreatic cancer: Is upfront resection worthwhile? 104
Intraductal papillary mucinous neoplasms and chronic pancreatitis. 100
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 93
Acoustic radiation force impulse ultrasound imaging of pancreatic cystic lesions: preliminary results 92
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 90
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. 89
B-Cell Lymphoma Presenting as Acute Pancreatitis. 88
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 88
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases. 87
Adequacy of Lymph Node Retrieval for Ampullary Cancer and Its Association with Improved Staging and Survival. 87
Role of Resection of the Primary Pancreatic Neuroendocrine Tumour Only in Patients with Unresectable Metastatic Liver Disease: A Systematic Review. 86
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years 86
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations. 83
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 83
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. 82
Enhanced recovery pathways in pancreatic surgery: State of the art 81
Italian consensus guidelines for chronic pancreatitis 80
Alchool intake,cigarette smoking and body mass index in patients with alcohol associated pancreatitis 80
Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study. 80
A systematic review on robotic pancreaticoduodenectomy. 80
The role of disease causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. 79
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors 78
Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis 77
Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian association for the study of the pancreas. 77
Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI. 77
A preoperative score to predict early death after pancreatic cancer resection 77
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 77
A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma. 76
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. 76
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. 76
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. 76
Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms 76
Absence of mutations in the transforming growth factor-beta inducible early gene 1, TIEG1, in pancreatic cancer. 75
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 75
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. 72
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. 72
Allelotype of pancreatic acinar cell carcinoma. 72
Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography 72
Alcohol intake, cigarette smoking, and body mass index in patients with alcohol-asociated pancreatitis 72
A single istitution experience with fistulojejunostomy for external pancreatic fistulas 70
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 70
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 70
Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study. 70
Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. 70
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System. Well-Differentiated Pancreatic Non-Functioning Tumors. 69
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. 69
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. 69
Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11 69
Anastomotic leakage in pancreatic surgery. 69
Discussion on prophylactic antibiotic treatment in patients with predicted severe pancreatitis: a placebo-controlled, double-blind trial 68
Neuroendocrine Tumor Disease- An Evolving Landscape. 68
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms. 68
Current status of robotic distal pancreatectomy: a systematic review. 68
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. 68
Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts-A shape shifting outlook into an increasingly recognized disease. 67
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. 67
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 67
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomized controlled trial 67
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides. 67
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal. 67
Pancreas: Insulinoma--new insights into an old disease. 66
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 66
Extent of surgical resections for intraductal papillary mucinous neoplasms. 66
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside. 66
Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: A position paper from the Italian Registry 66
Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 65
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 65
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy 65
Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. 65
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries 65
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology 65
Acute necrotizing pancreatitis and fistula treatment: the role of somatostatin - 14 and its analogues. 64
Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. 64
Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma 64
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 64
Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1. 63
TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study. 63
Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. 63
Re: "long-term comparison of laparoscopy-assisted distal gastrectomy and open distal gastrectomy in advanced gastric cancer" (Surg Endosc (2010) 24:1:63-67). 63
Adenocarcinoma pancreatico umano primario ed espressione dell’ossido nitrico sintetasi inducibile e cicloossigenasi–2. 62
Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. 62
Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases. 62
Somatostatin analogs: is one better than other? 62
SILS cholecystectomy, early experience of a single institution: pilot study of 21 cases. 61
Rectal indomethacin to prevent post-ERCP pancreatitis. 61
Enucleation of pancreatic neoplasms. 61
[Closed surgical treatment in acute severe pancreatitis] 61
Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression 61
Questions about branch-duct IPMNs with Sendai negative criteria. 61
Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach. 61
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. 61
Minimally invasive necrosectomy versus conventional surgery in the treatment of infected pancreatic necrosis: a systematic review and a meta-analysis of comparative studies. 60
Treatment trends in metastatic pancreatic cancer patients: Is it time to change? 60
Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen's disease. 60
Pancreatic enzyme replacement therapy after gastric resection: An update 60
Imaging of neuroendocrine gastroenteropancreatic tumours 59
Laparoscopic ileocecal resection for bowel endometriosis. 59
Pancreatic Pathology (Special Topics) 59
Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor 59
Autoimmune pancreatitis: a challenging diagnostic puzzle for clinicians. 59
Totale 7.107
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.237 194 530 522 77 616 272 378 307 395 331 400 215
2021/20222.074 123 565 12 93 3 179 78 149 116 209 51 496
2022/20231.886 367 189 228 61 56 120 2 32 736 3 49 43
2023/20241.386 328 7 32 349 325 145 18 9 1 8 4 160
2024/20253.651 227 535 39 9 66 21 521 105 1.113 252 299 464
2025/2026184 184 0 0 0 0 0 0 0 0 0 0 0
Totale 17.782